New options for testing and treating some of the most common sexually transmitted diseases are becoming available ...

Pills for Erectile dysfunction for men, Effective Formula for last longer and testosterones booster Quality Criteria Examined ...

Comprehensive Ingredient Analysis and Clinical Study References Compiled as Post-Holiday Search Interest in Natural ...

Some tout a daily semaglutide pill as a game-changer for weight-loss treatment. The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo ...

The Food and Drug Administration on Monday approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight loss drug. The Wegovy pill, as it’s called, is first oral version of a GLP-1 drug that ...

The US Food and Drug Administration today approved a pill version of the blockbuster anti-obesity drug Wegovy. Made by Novo Nordisk, the pill is taken once a day. The company’s original version of ...

The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk’s weight-loss drug Wegovy, introducing a new option for how patients can take medicines in a class of drugs ...

Anti-abortion voices are growing increasingly impatient for the Trump administration to complete a review of the abortion pill mifepristone, potentially altering its approval. But changing abortion ...

In a new trial, people who switched to the experimental daily GLP-1 pill orforglipron were able to keep off most of the weight they had lost taking Wegovy or Zepbound. People who switched from Wegovy ...

FDA chief's office said it wants to cut the filing review from 60 days to one week The office said it may cut those reviews to two or three weeks based on complexity The agency could decide on Lilly's ...

Top officials at the U.S. FDA have internally urged its reviewers to speed up the evaluation of Eli Lilly’s (LLY) marketing application for its weight loss pill orforglipron after the Indiana-based ...

Pro-life advocates are calling for action as top federal health officials deny reports that they are delaying a promised safety review of the abortion pill. The Food and Drug Administration (FDA), an ...